Irhythm Technologies Inc (NASDAQ:IRTC) CFO Matthew C. Garrett sold 42,910 shares of the company’s stock in a transaction dated Friday, January 5th. The shares were sold at an average price of $59.17, for a total transaction of $2,538,984.70. Following the completion of the transaction, the chief financial officer now owns 36,085 shares in the company, valued at $2,135,149.45. The transaction was disclosed in a filing with the SEC, which is available at this link.
Irhythm Technologies Inc (IRTC) opened at $60.04 on Thursday. The firm has a market cap of $1,390.00 and a PE ratio of -50.45. Irhythm Technologies Inc has a 1-year low of $28.70 and a 1-year high of $60.81. The company has a current ratio of 7.65, a quick ratio of 7.57 and a debt-to-equity ratio of 0.38.
Irhythm Technologies (NASDAQ:IRTC) last announced its quarterly earnings data on Wednesday, November 1st. The company reported ($0.29) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.34) by $0.05. The business had revenue of $25.04 million for the quarter, compared to analyst estimates of $24.30 million. Irhythm Technologies had a negative net margin of 27.56% and a negative return on equity of 27.67%. The company’s revenue was up 49.2% on a year-over-year basis. During the same period in the prior year, the firm posted ($2.80) EPS. research analysts anticipate that Irhythm Technologies Inc will post -1.17 earnings per share for the current year.
Institutional investors and hedge funds have recently bought and sold shares of the stock. Legal & General Group Plc increased its position in Irhythm Technologies by 131.0% during the 2nd quarter. Legal & General Group Plc now owns 3,373 shares of the company’s stock worth $143,000 after purchasing an additional 1,913 shares in the last quarter. Advisor Group Inc. increased its position in Irhythm Technologies by 763.9% during the 3rd quarter. Advisor Group Inc. now owns 2,920 shares of the company’s stock worth $151,000 after purchasing an additional 2,582 shares in the last quarter. Voya Investment Management LLC acquired a new stake in Irhythm Technologies during the 2nd quarter worth approximately $274,000. GSA Capital Partners LLP acquired a new stake in Irhythm Technologies during the 2nd quarter worth approximately $289,000. Finally, Nationwide Fund Advisors increased its position in Irhythm Technologies by 92.8% during the 2nd quarter. Nationwide Fund Advisors now owns 7,843 shares of the company’s stock worth $333,000 after purchasing an additional 3,774 shares in the last quarter. 97.80% of the stock is owned by hedge funds and other institutional investors.
About Irhythm Technologies
iRhythm Technologies, Inc is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report.
Receive News & Ratings for Irhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.